AXGN Stock Analysis: Buy, Sell, or Hold?
AXGN - Axogen, Inc. Common Stock
$34.44
0.86 (2.56%)
▲
5d:
+6.79%
30d:
+17.86%
90d:
+5.22%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Distribution
AXGN is up 5.7% this week, but smart money is buying puts. Top strike: $35 2026-05-15 with 5 OI. Put ratio: 100% View Scanner →
Strength: 7.8/10
Get Alerted When AXGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AXGN shows positive signals but monitor for confirmation. Market pricing in 8.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: AXGN shows positive signals but monitor for confirmation. Market pricing in 8.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$37.63
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$23.36
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AXGN is currently trading at $34.44, which is considered extended relative to its 30-day fair value range of $30.12 to $33.23. From a valuation perspective, the stock is trading at a discount (Forward PE: 44.6) compared to its historical average (57.2). Remarkably, the market is currently pricing in an annual earnings decline of 8.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AXGN is in a strong uptrend. The price is approaching resistance at $34.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AXGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $40.56 (+17.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AXGN is in a strong uptrend. The price is approaching resistance at $34.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AXGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $40.56 (+17.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$30.12 -
$33.23
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
67.3%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($40.56)
Fair Price Analysis
30-Day Fair Range
$30.12 -
$33.23
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$3.32
(9.6%)
Support & Resistance Levels
Support Level
$30.00
Resistance Level
$34.46
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
44.56
Wall Street Target
$40.56
(+17.8%)
Revenue Growth (YoY)
21.3%
Profit Margin
-7.0%
Valuation Discount vs History
-8.0% cheaper
PE vs Historical
44.6 vs 57.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.0%
(market-implied from PE analysis)
1-Year Target
$31.68
(-8%)
2-Year Target
$29.15
(-15%)
3-Year Target
$26.82
(-22%)
3-Yr Target (if PE normalizes)
(PE: 45→57)
$34.43
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 44.6, Growth: 43.9%)
$102.63
(+198%)
Base:
(SPY PE: 20.6, Growth: 43.9%)
$47.38
(+38%)
Bear:
(PE: 17.5, Growth: 43.9%)
$40.27
(+17%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 44.6 to 57.2
Stabilization Target:
$44.21
(+28.4%)
PE Expansion Potential:
+28.4%
Share & Embed Analysis
Last updated: April 02, 2026 7:06 PM ET
Data refreshes hourly during market hours. Next update: 8:06 PM
Data refreshes hourly during market hours. Next update: 8:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AXGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Erick Wayne Devinney
SELL
5221 shares
2026-03-16
Amy Mcbride Wendell
SELL
43684 shares
2025-12-16
Kathy Johnson Weiler
SELL
46653 shares
2025-12-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 56 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 62 BUY |
Advanced AXGN Option Strategies
Professional options setups generated by AI based on today's AXGN price and gamma walls.
